+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Bladder Cancer Drugs Market Research Reports

Bladder cancer is the fourth most common cancer among males in the US and due to its prevalence among the over 65s, diagnoses are set to increase in ageing populations worldwide. Reports in the Bladder Cancer section cover a variety of areas, such as the latest R&D and clinical trials taking place in universities, hospitals and other research centres around the world. Explore epidemiology, unmet needs, drug development (cytotoxic, immunotherapy agents, etc.), supply & demand, business development strategies, licensing and partnership opportunities, and the activities of key industry players such as Bristol-Myers Squibb, Spectrum Pharmaceuticals, Bioniche Life Sciences, Endo Pharmaceuticals, Eli Lilly and Sanofi-Aventis. Show Less Read more

Global Bladder Cancer Partnering 2010 to 2017 - Product Thumbnail Image

Global Bladder Cancer Partnering 2010 to 2017

  • Report
  • March 2017
  • 150 Pages
From
From
Methotrexate (CAS 59-05-2) Market Research Report 2017 - Product Thumbnail Image

Methotrexate (CAS 59-05-2) Market Research Report 2017

  • Report
  • February 2017
  • 70 Pages
From
From
Global and Chinese Doxorubicin hcl Industry - 2017 - Product Thumbnail Image

Global and Chinese Doxorubicin hcl Industry - 2017

  • Report
  • March 2017
  • 150 Pages
From
Global and Chinese Mitomycin Industry - 2017 - Product Thumbnail Image

Global and Chinese Mitomycin Industry - 2017

  • Report
  • March 2017
  • 150 Pages
From
Global and Chinese Cisplatin Industry - 2017 - Product Thumbnail Image

Global and Chinese Cisplatin Industry - 2017

  • Report
  • March 2017
  • 150 Pages
From
From
CAS 59-05-2 Methotrexate Chemical World Report - Product Thumbnail Image

CAS 59-05-2 Methotrexate Chemical World Report

  • Report
  • April 2017
  • 2111 Pages
From
From
From
From
From
From
Loading Indicator
adroll